SCHEMBL7608317

SCHEMBL7608317

COc1ccc(-c2cc3ncccc3[nH]2)c(C=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.44
KDM5A P29375 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
KDM5B Q9UGL1 1/20 0.42
ITK Q08881 2/20 0.42
CCNB2 O95067 3/20 0.41
CDK1 P06493 3/20 0.41
CCNB1 P14635 3/20 0.41
CDK5 Q00535 3/20 0.41
CDK5R1 Q15078 3/20 0.41
CCNB3 Q8WWL7 3/20 0.41
AURKB Q96GD4 2/20 0.41
PLK4 O00444 1/20 0.41
CHEK1 O14757 1/20 0.41
AURKA O14965 1/20 0.41
ABL1 P00519 1/20 0.41
PDGFRB P09619 1/20 0.41
CDK4 P11802 1/20 0.41
SRC P12931 1/20 0.41
CCNA2 P20248 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7066067 0.80 KDM4E (0.57) ITKCHEK1AURKAPDGFRBKDR
SCHEMBL7060431 0.74 KDM4C (0.47) KDM5AKDM4CKDM5BAURKBAURKA
SCHEMBL29613261 0.74 ERN1 (0.46) PDE2AALDH1A1ERN1TRIM24TYR
SCHEMBL28732809 0.74 ERN1 (0.46) PDE2AALDH1A1ERN1TRIM24TYR
SCHEMBL29464785 0.74 MAOA (0.48) ALDH1A1ERN1TRIM24TYRTRIM33
SCHEMBL7060435 0.74 KDM4C (0.46) PDE2AKDM5AKDM4CKDM5BITK
SCHEMBL20125301 0.72 KDM4C (0.67) KDM5AKDM4CKDM5BCCNB2CDK1
SCHEMBL7066063 0.69 MEN1 (0.59) ITKAURKAPDGFRBKDRFLT3
SCHEMBL3677398 0.68 ERN1 (0.56) ALDH1A1ERN1TRIM24TYRTRIM33
SCHEMBL7608310 0.68 KDM4E (0.39) PDE2ACCNB2CDK1CCNB1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents BECKERS THOMAS (DE) 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT PDE2A 3917/4885KDM5A 1677/4885KDM4C 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.